Akebia Therapeutics
AKBA
AKBA
139 hedge funds and large institutions have $399M invested in Akebia Therapeutics in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 144 → 139 (-5)
19% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 21
39% less call options, than puts
Call options by funds: $2.3M | Put options by funds: $3.77M
Holders
139
Holding in Top 10
1
Calls
$2.3M
Puts
$3.77M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$14.2M | |
| 3 | +$7.13M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.69M |
| 5 |
BlackRock
New York
|
+$3.05M |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$4.11M | |
| 3 | -$2.58M | |
| 4 |
Two Sigma Advisers
New York
|
-$2.31M |
| 5 |
Two Sigma Investments
New York
|
-$2.12M |